Ascendis Pharma A/S (ASND)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Ascendis Pharma A/S’s filings yet. We add companies and filings all the time.
Track ASND and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| FMR LLC | Aug 13, 2026 | $945.68M |
| Artisan Partners Limited Partnership | Aug 13, 2026 | $702.55M |
| BlackRock, Inc. | Aug 7, 2026 | $589.94M |
| Capital International Investors | Aug 12, 2026 | $530.4M |
| Massachusetts Financial Services Company | Aug 3, 2026 | $500.14M |
ASND's filings are public. The insight is one click away.
Scrutar's AI reads every ASND filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a ASND filing.
Get an email when ASND files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 24, 2026Source: SEC EDGAR.